Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas

Journal of Oral Pathology and Medicine

Volumn 35, Issue 3, 2006, Pages 183-189

  Kumamoto, Hiroyuki ^a   Ooya, Kiyoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; Cell cycle; E2 promoter binding factor 1; Retinoblastoma protein

Indexed keywords

ANTIBODY; KI 67 ANTIGEN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

AMELOBLASTOMA; ANTIGEN DETECTION; ARTICLE; BASEMENT MEMBRANE; BENIGN TUMOR; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GERM LAYER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; TOOTH DEVELOPMENT; TUMOR CLASSIFICATION;

AMELOBLASTOMA; E2F1 TRANSCRIPTION FACTOR; HUMANS; KI-67 ANTIGEN; RETINOBLASTOMA PROTEIN; STATISTICS, NONPARAMETRIC; TOOTH GERM;

EID: 33645220110     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2006.00381.x     Document Type: Article

References (43)

1. Kramer IRH Pindborg JJ Shear M. WHO histological typing of odontogenic tumours. Berlin, Germany Springer-Verlag 1992 11 27.
2. Melrose RJ. Benign epithelial odontogenic tumors. Semin Diagn Pathol 1999 16 271 87.
3. Eversole LR. Malignant epithelial odontogenic tumors. Semin Diagn Pathol 1999 16 317 24.
4. Sciubba JJ Fantasia JE Kahn LB. Tumors and cysts of the jaw.
5. Heikinheimo K Jee KJ Niini T et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 2002 81 525 30.
6. Jaakelainen K Jee KJ Leivo I Saloniemi I Knuutila S Heikinheimo K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet 2002 136 31 7.
7. Beijersbergen RL Bernards R. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim Biophys Acta 1996 287 103 20.
8. Sherr CJ Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999 13 1501 12.
9. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995 81 323 30.
10. Chellappan SP Hiebert S Mudryj M Horowitz JM Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991 65 1053 61.
11. Mihara K Cao XR Yen A et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989 246 1300 3.
12. Lavia P Jansen-Durr P. E2F target genes and cell-cycle checkpoint control. Bioessays 1999 21 221 30.
13. Toguchida J Ishizaki K Sasaki MS et al. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 1988 48 3939 43.
14. Lee EY To H Shew JY Bookstein R Scully P Lee WH. Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988 241 218 21.
15. Bookstein R Shew JY Chen PL Scully P Lee WH. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 1990 247 712 5.
16. Suzuki T Yasui W Yokozaki H Naka K Ishikawa T Tahara E. Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer 1999 81 535 8.
17. Gorgoulis VG Zacharatos P Mariatos G et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002 198 142 56.
18. Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 1997 26 419 25.
19. Kumamoto H Kimi K Ooya K. Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 2001 30 309 15.
20. Pande P Mathur M Shukla NK Ralhan R. pRb and p16 protein alterations in human oral tumorigenesis. Oral Oncol 1998 34 396 403.
21. Rabbani F Richon VM Orlow I et al. Prognostic significance of transcription factor E2F-1 in bladder cancer: genotypic and phenotypic characterization. J Natl Cancer Inst 1999 91 874 81.
22. Hedberg Y Ljungberg B Roos G Landberg G. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins. Int J Cancer 2004 109 189 93.
23. Jernvall J Aberg T Kettunen P Keranen S Thesleff I. The life history of an embryonic signaling center: BMP-4 induces p21 and is associated with apoptosis in the mouse tooth enamel knot. Development 1998 125 161 9.
24. Lee EY Chang CY Hu N et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992 359 288 94.
25. Morgenbesser SD Williams BO Jacks T DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994 371 72 4.
26. Yamasaki L Jacks T Bronson R Goillot E Harlow E Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 1996 85 537 48.
27. Field SJ Tsai FY Kuo F et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996 85 549 61.
28. Friend SH Bernards R Rogelj S et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986 323 643 6.
29. Harbour JW Lai SL Whang-Peng J Gazdar AF Minna JD Kaye FJ. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988 241 353 7.
30. Gorgoulis VG Zacharatos P Kotsinas A et al. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Am J Pathol 1998 153 1749 65.
31. Yamamoto H Soh JW Monden T et al. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin Cancer Res 1999 5 1805 15.
32. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med 1995 24 393 7.
33. Sherr CJ. Cancer cell cycles. Science 1996 274 1672 7.
34. Tsuda H Yamamoto K Inoue T Uchiyama I Umesaki N. The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma. Br J Cancer 2000 82 675 82.
35. Kamb A Gruis NA Weaver-Feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 264 436 40.
36. Donnellan R Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998 51 1 7.
37. Kovesdi I Reichel R Nevins JR. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 1986 45 219 28.
38. Zhang SY Liu SC Johnson DG Klein-Szanto AJ. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res 2000 60 5972 6.
39. Pierce AM Schneider-Broussard R Gimenez-Conti IB Russell JL Conti CJ Johnson DG. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol 1999 19 6408 14.
40. ARF links the tumour suppressors RB and p53. Nature 1998 395 124 5.
41. Lissy NA Davis PK Irwin M Kaelin WG Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 2000 407 642 5.
42. ARF proteins in ameloblastomas. J Oral Pathol Med 2004 33 292 9.
43. Kumamoto H Ohki K Ooya K. Expression of p63 and p73 in ameloblastomas. J Oral Pathol Med 2005 34 220 6.